Stories of Survival in Africa

Stories of Survival in Africa

[vc_video link=’https://www.youtube.com/watch?v=uSbC8UEsBXE’]

Thousands of patients are diagnosed with chronic myeloid leukaemia (CML) annually around the world. CML, like any other cancer, does not discriminate. It affects people from all regions and walks of life. However, unlike many other cancers, CML has an amazing story due to advancements made in its treatment in the last decade. It was only 15 years ago that a patient newly diagnosed with CML would have a prognosis of survival of less than 5 years with the treatments available at the time.

The story of CML goes hand in hand with how lives can be changed even in remote areas of the world once patients have access to the latest treatment, regardless of affordability. Each one of the three cancer survivors and advocates featured in the video want you to know that life and survival is dear to all, regardless of where you are from. They tell their individual stories of survival and are able to share it with us because they were given the gift of life when they so needed it. Now, they are able to give of themselves to other patients. Today we will be sharing the powerful stories of how access to treatment, especially in remote areas, can change the course of the relationship between disease and patient. We invite you to listen to these stories and call on you to join us and urge your respective governments to lay the pathway for access to treatment for all cancer patients and give the gift of life, hope and dignity that every patient deserves.

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Maximize Life Campaign: A Variety of Events but a Shared Message in Latin America

    The Maximize Life Campaign: A Variety of Events but a Shared Message in Latin America

    In Latin America, the Maximize Life Campaign has become something like a tradition – a time when each patient organization creates an event or activity of their choice and powers it up for a campaign that takes on a life of its own!

    13 patient groups from 11 Latin American countries joined this year’s movement, bringing together patients and caregivers with the purpose of telling the community that cancer is an issue, that ignoring it is not going to make it go away, and that the best approach is to learn about it in order to know what to do about it. From governments to the general public, everybody can get involved in figuring out how to treat cancer patients as members of society and not as a burden.

  • A story of Hope from a Doctor’s Perspective.

    A story of Hope from a Doctor’s Perspective.

    My name is Dr. Temilola Owojuyigb; I work in the Hematology and Blood Transfusion Unit, Ile-Ife, Nigeria. I decided to specialize in Hematology because hematological diseases are not often diagnosed or diagnosed late in affected persons due to a scarcity of experts. Thus, patients either do not get treatment or get treated when many complications….

  • Finding Value in the Patient Experience

    Finding Value in the Patient Experience

    Health systems around the world are strained due to the high burden of costs. In an attempt to guide decision-makers in their choices on behalf of patients, the topic of value frameworks was born. These value frameworks evaluate all aspects of cancer treatment: clinical benefit, side effects, and improvement in patient symptoms or quality of life. But given the complexities of the multitude of health systems around the world, it is not a straightforward discussion. And right now, it’s a dialogue driven by thought leaders and health economists from the US and Europe. But there are critical voices is missing from this discussion: patients and patient advocates.